Several biomarkers of kidney function, such as proteinuria and eGFR, are considered standard in the management of IgA nephropathy. In this brief overview, Dr. Richard Lafayette discusses the potential role of emerging biomarkers in diagnosis, prognosis, treatment selection, and treatment response.1
References: 1. Selvaskandan H, Shi S, Twaij S, Cheung CK and Barratt J (2020) Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management. Front. Immunol. 11:572754. https://doi.org/10.3389/fimmu.2020.572754